Hard to heal pressure ulcers (stage III-IV): Efficacy of injected activated macrophage suspension (AMS) as compared with standard of care (SOC) treatment controlled trial

Adi Zuloff-Shani*, Abraham Adunsky, Aviva Even-Zahav, Haim Semo, Arie Orenstein, Jeremy Tamir, Eli Regev, Eilat Shinar, David Danon

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Hard to heal pressure ulcers (stage III-IV): Efficacy of injected activated macrophage suspension (AMS) as compared with standard of care (SOC) treatment controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences